Therefore, the cancer cells disrupt the balance between RANKL and OPG in the bone environment, leading to an excess of bone resorption and loss (osteolytic lesions) or apposition of abnormal bone (osteoblastic lesions) [117]. Here, TNFRSF11B is linked to cancer.